ORNBV Orion Oyj Class B

Orion Research Foundation grants EUR 1,109,000 for research in 2025

Orion Research Foundation grants EUR 1,109,000 for research in 2025

Orion Research Foundation grants EUR 1,109,000 for research in 2025

Press release 22 November, 2024 at 9.00 EET

Orion Research Foundation sr is distributing EUR 1,109,000 in research grants based on applications for 2025. Orion Research Foundation awards grants of max EUR 50,000 for 19 researchers for postdoctoral research and max EUR 6,000 for 93 young researchers for doctoral dissertation work. 

Orion Research Foundation sr is annually distributing its return on investment and donations from Orion Corporation as grants for young researchers for doctoral dissertation work and postdoctoral research. In the last few years the Research Foundation has been distributing annual grants based on applications for the total sum of MEUR 1 for research in medicine, veterinary medicine, pharmacy and related sciences, such as chemistry and physics.

Grants for 2025

Grants for postdoctoral research, EUR 25,000 – 50,000 

Aatsinki Anna-Katariina, LT, Turun yliopisto, Toiminnalliset vatsavaivat ja suolistomikrobiston kehitys lapsuudessa, EUR 25,000

Acosta Manzano Francisco Miguel, Researcher, Turun yliopisto, Medicity (University of Turku) and Turku PET Centre (Turku University Hospital), Unlocking the Power of Brown Fat: New Targets in the Fight Against Cardiometabolic Disease, EUR 50,000

Awad Shady, M.D., Ph.D., University of Oxford, Oxford, UK, Identification of Molecular Vulnerabilities Role in TP53-mutant Leukemic Evolution of Myeloproliferative Neoplasms, EUR 25,000

Carpén Timo Pertti Mikael, LKT, dosentti, erikoislääkäri, palliatiivinen erityispätevyys, Helsingin yliopisto, Virtual symptom screening with Targeted Early Palliative care (STEP2) versus usual care for patients with advanced cancer: a randomized controlled trial., EUR 40,000

Göös Helka Linnea, FT, Suomen Punainen Risti, Veripalvelu, Enhancing CAR-NK cell effectiveness using base editing, EUR 25,000 €

Häkli Martta Ida Emilia, Tekniikan tohtori, Center for iPS Cell Research and Application, Kyoto University, Hypertrofinen kardiomyopatia kantasolupohjaisissa sydänorganoideissa, EUR 30,000

Kim Daehong, Postdoc Fellow, University of Zurich, University of Helsinki, Unravelling gastrointestinal graft-versus-host disease: Organoid transplantation and advanced immune profiling in preclinical models, EUR 25,000 €

Korvenlaita Nea Karoliina, Farmasian tohtori, Johns Hopkins School of Medicine, Department of Molecular & Comparative Pathobiology, Baltimore, USA, Aivosairauksien diagnostiikkaa uusin menetelmin: Solunulkoisista vesikkeleistä parempia biomarkkereita, EUR 50,000

Kositsky Adam, FT, Itä-Suomen yliopisto Kuopion kampus, Piezo1 for Tendon: Understanding Biomechanical and Bioregenerative Effects (PiezTUBBE), EUR 30,000

Koskinen Maija-Kreetta, Filosofian tohtori, Helsingin yliopisto, Sleep well and keep calm: Neural mechanisms of sleep disruption-induced anxiety, EUR 25,000

Laivuori Silja Mirjami, Lääketieteen tohtori, Helsingin yliopisto, Peripheral arterial disease in women., EUR 25,000

Lautaoja-Kivipelto Juulia Helene, Liikuntatieteiden tohtori, Oulun yliopisto, The effects of exercise on adipose tissue mitochondrial function and NAD+ metabolism, EUR 30,000

Muroke Valtteri, LT, Helsingin yliopisto, Helsingin Yliopistollinen Keskussairaala, Inflammation and coronary artery disease - Effects of colchicine on proteomic and metabolomic biomarkers in the COLCOT trial, EUR 40,000

Mäkitaipale Heidi Johanna, ELT, pieneläinsairauksien erikoiseläinlääkäri, Helsingin yliopisto, Kaniinien suun mikrobiomi ja sen yhteys krooniseen hammassairauteen, EUR 30,000

Parvanian Sepideh, PhD, MBA, Åbo Akademi, Cell biology department, Contrasting immunogenic and non-immunogenic bladder tumors: immune microenvironment, metabolic influences, and therapeutic resistance, EUR 25,000

Rajamaki Blair, Researcher, Itä-Suomen yliopisto Kuopion kampus, Temporal changes to comorbidity clusters in people with type 2 diabetes in Finland and Australia, EUR 25,000

Savukoski Susanna Marianne, Lääketieteen tohtori, Oulun yliopisto, Hormonikorvaushoidon pitkäaikaiset terveysvaikutukset ennenaikaisesti vaihdevuosiin tulleilla naisilla, EUR 40,000

Urpa Lea Martta, Researcher, Helsingin yliopisto, Understanding the relationship between disordered sleep and autism symptomatology, EUR 40,000

Yrjölä Pauliina Anna Henriikka, Tekniikan tohtori, sairaalafyysikko, Helsingin yliopisto, Biomarkers of adverse structural-functional development in preterm infants, EUR 30,000

Orion Reaserch Foundation awards grants of max EUR 50,000 for 19 researchers for postdoctoral research. These grants are in total EUR 610,000.

Grants for doctoral dissertation work, EUR 3,000 – 6,000

In addition, Orion Research Foundation has awarded EUR 3,000 – 6,000 for 93 researchers for doctoral dissertation work. These grants are in total EUR 499,000.

Orion Research Foundation sr

More info:

Siiri Lehtinen

Head of Orion Research Foundation

Tel: +358 (0)10 426 4409

siiri.lehtinen(at)orion.fi

Publisher

Orion Research Foundation sr

Attachment



EN
22/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Orion Oyj Class B

 PRESS RELEASE

Orion Research Foundation grants EUR 1,109,000 for research in 2025

Orion Research Foundation grants EUR 1,109,000 for research in 2025 Orion Research Foundation grants EUR 1,109,000 for research in 2025 Press release 22 November, 2024 at 9.00 EET Orion Research Foundation sr is distributing EUR 1,109,000 in research grants based on applications for 2025. Orion Research Foundation awards grants of max EUR 50,000 for 19 researchers for postdoctoral research and max EUR 6,000 for 93 young researchers for doctoral dissertation work.  Orion Research Foundation sr is annually distributing its return on investment and donations from Orion Corporation as grants...

 PRESS RELEASE

Orionin Tutkimussäätiö myöntää vuodelle 2025 tutkimukseen apurahoina y...

Orionin Tutkimussäätiö myöntää vuodelle 2025 tutkimukseen apurahoina yhteensä 1 109 000 euroa Orionin Tutkimussäätiö myöntää vuodelle 2025 tutkimukseen apurahoina yhteensä 1 109 000 euroa Lehdistötiedote 22.11.2024 klo 9.00 Orionin Tutkimussäätiö sr:n hallitus on julkistanut 22.11.2024 myönnettäväksi apurahoja hakemusten perusteella 1 109 000 euroa apurahoina vuodelle 2025. Hakemuksesta myönnettiin suuria, enintään 50 000 euron suuruisia apurahoja 19 äskettäin väitelleelle tutkijalle tutkimustyön jatkamiseen. Enintään 6 000 euron suuruisia apurahoja myönnettiin hakemuksesta 93 väitöskirj...

 PRESS RELEASE

Orion and Alligator Bioscience amend their agreement concerning two bi...

Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies ORION CORPORATION INVESTOR NEWS 19 NOVEMBER 2024 at 18.30 EET                Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies Orion Corporation and Alligator Bioscience AB have agreed on the conversion of the previously granted royalty-bearing license to Orion Corporation to two bispecific antibodies that the companies have been successfully developing in collaboration using Alligator’s RUBY® bispecific format to a perpetual, fully paid, royalty-free ...

Orion Oyj: 1 director

A director at Orion Oyj bought 2,000 shares at 44.650EUR and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

 PRESS RELEASE

Orion Corporation: Managers’ transactions – Henrik Stenqvist

Orion Corporation: Managers’ transactions – Henrik Stenqvist ORION CORPORATION MANAGERS’ TRANSACTIONS 1 NOVEMBER 2024 at 9.45 EET Orion Corporation: Managers’ transactions – Henrik Stenqvist Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. Orion Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Henrik StenqvistPosition: Member of ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch